Drugs / Docetaxel
Docetaxel
Drug Approved in the United States; prescription-onlyTaxane chemotherapy·First approved·1995
- Registered trials
- 1615
- Ongoing
- 319/ 20%
- Completed
- 846
- Indications
- 5
Approved indications
| Indication |
|---|
| Breast cancer |
| Head and neck cancer |
| Stomach cancer |
| Prostate cancer |
| Non-small-cell lung cancer |
Clinical trial landscape
1615 registered studies reference this molecule or one of its brands. The split below shows how many are ongoing versus completed per phase.
| Phase | Total | Ongoing | Completed | Split |
|---|---|---|---|---|
| Phase 2 | 779 | 129 | 410 | |
| Phase 3 | 359 | 102 | 186 | |
| Phase 1 | 224 | 26 | 138 | |
| Phase 1/2 | 140 | 30 | 67 | |
| Phase 2/3 | 43 | 17 | 9 | |
| Not applicable | 27 | 6 | 11 | |
| Unknown | 23 | 6 | 15 | |
| Phase 4 | 17 | 3 | 8 | |
| Early Phase 1 | 3 | 0 | 2 | |
| All phases | 1615 | 319 | 846 |
Ongoing Completed Balance withdrawn, terminated, or status unreported.
Study records: ClinicalTrials.gov →
Mechanism of action
Disrupts normal microtubule function and thereby blocks cell division.
Recent developments
Headlines link to the original publisher. Sources limited to a reviewed list of journals, regulators, and medical press.